vitrakvi - larotrectinib capsule
(Larotrectinib)Loxo Oncology, Inc.
Tropomyosin Receptor Kinases Inhibitors [MoA] class drugs
2 results
vitrakvi - larotrectinib capsule
(Larotrectinib)Bayer Healthcare Pharmaceuticals Inc.Usage: Vitrakvi treats adult and pediatric patients with solid tumors harboring an NTRK gene fusion (without acquired resistance), when tumors are metastatic or surgery would cause severe morbidity, and no satisfactory alternatives exist or prior treatment has failed.